ACADIA PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.86 USD | -2.11% |
|
-13.86% | -52.54% |
| 10/05 | UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating | MT |
| 10/05 | Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | -2.11% | -13.86% | -52.54% | -30.79% | -41.95% | 250.81Cr |  | | |
- Stock Market
- Equities
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.
- Relative Strength Chart